All Novartis news

23 hours ago Taking breast cancer prevention drug beyond 5 years may not raise survival - WECT 6 Wilmington
Yesterday Taking breast cancer prevention drug beyond 5 years may not raise survival - WIS News 10 Columbia
Yesterday Taking breast cancer prevention drug beyond 5 years may not raise survival - WLBT 3 Jackson
Yesterday Taking breast cancer prevention drug beyond 5 years may not raise survival - KTRE Lufkin and Nacogdoches
Yesterday Taking breast cancer prevention drug beyond 5 years may not raise survival - WALB Albany
Yesterday Taking breast cancer prevention drug beyond 5 years may not raise survival - WTVM 9 Columbus
Yesterday Taking breast cancer prevention drug beyond 5 years may not raise survival - KFVS 12 Cape Girardeau
Yesterday ‘Evolutions and revolutions’ in chronic disease care - SciDev.net
Yesterday Amgen Inc. vs. Pfizer - FOX Business
Yesterday Amgen Inc. vs. Pfizer - FOX Business
Yesterday Rapid Microbiological Methods Alternatives To Colony Forming Units A Pathway To Implementation - PharmaceuticalOnline
Yesterday Imagine Dragons lead singer lends voice to 'hidden disease' - FOX News
Yesterday A work of art from Maya Lin on Mass. Ave. - Boston Globe
Yesterday Is This Why CRISPR Therapeutics Stock Rallied 21.6% in November? - FOX Business
Yesterday Is This Why CRISPR Therapeutics Stock Rallied 21.6% in November? - FOX Business
Yesterday A Meeting. A Vow. A New Hope for Childhood Health. - Fortune
2 days ago Novartis in talks to sell some central nervous system drugs - Channel NewsAsia
2 days ago U.S. Patent Agency Weighs Rival Claims on Gene-Editing Technology - Fortune
2 days ago Has GlaxoSmithKline Finally Turned the Corner? - FOX Business
2 days ago Has GlaxoSmithKline Finally Turned the Corner? - FOX Business
2 days ago In brief: CCgroup wins Mitek, Dole hires Threepipe, Aquila appoints Red Lorry Yellow Lorry - PRWeek UK
2 days ago Sanofi Said to Explore Counterbid for Actelion Amid J&J Talks - Swissinfo
3 days ago New Drug Effective in 82 Percent of Leukemia Patients - Newsmax
3 days ago Stem Cells Improve Motor Function in Stroke Victims - Newsmax
3 days ago Novartis says 82 percent of leukemia patients in remission after CAR - FOX News
3 days ago Fondation IPSEN Colloques Médecine et Recherche: Endocrinologie - Business Wire
3 days ago Fondation IPSEN Colloques médecine et recherche: Endocrinology - Business Wire
3 days ago Pooled Analysis of Five-Year Data from Two Phase 3 Studies Further Supports Overall Survival Advantage Observed in Patients with Myelofibrosis Treated With Jakafi® (ruxolitinib) - Business Wire
3 days ago Alnylam Reports Positive Interim Clinical Results for Fitusiran from Ongoing Phase 2 Open Label Extension Study in Patients with Hemophilia A or B without Inhibitors - Business Wire
4 days ago Novartis CEO plays down prospects for Actelion bid: Blick - Channel NewsAsia
4 days ago Novartis CEO plays down prospects for Actelion bid: Blick - Reuters
4 days ago Alnylam Reports Positive Interim Phase 1 Results for Fitusiran in Hemophilia A and B Patients with Inhibitors - Business Wire
4 days ago Alnylam Reports Positive Initial Clinical Activity Results for Givosiran (ALN-AS1), an Investigational RNAi Therapeutic for the Treatment of Acute Hepatic Porphyrias - Business Wire
5 days ago 3 Reasons Why Incyte Corporation Stock Could Soar in 2017 - FOX Business
5 days ago 3 Reasons Why Incyte Corporation Stock Could Soar in 2017 - FOX Business
5 days ago Zika scientists: We’re back to square one - Boston Herald
5 days ago Deaths in Cancer Trials Remain Mystery for Promising Therapy - Swissinfo
6 days ago Penn Medicine and Children's Hospital of Philadelphia Researchers to Present Latest Findings of Personalized Cellular Therapies at American Society of Hematology Meeting - University of Pennsylvania Health System
6 days ago If high-school kids in Australia can replicate a $750 drug for $2, why is it still so expensive to buy? - Quartz
6 days ago Study offers clue to link between rare narcolepsy cases, 1 vaccine during swine flu pandemic - FOX News
6 days ago Surface Oncology CD47 Program Demonstrates Promising Anti-Tumor Activity in Hematological Disease Models - Business Wire
6 days ago Magic mushroom drug psilocybin eases anxiety in cancer patients - NBC News
6 days ago Eisai names SVP for oncology business - NJ Biz
7 days ago Bluebird stock surges after myeloma treatment impresses in tiny study - CNBC
7 days ago Patients respond well in Bluebird’s clinical trial for multiple myeloma, raising hopes - Boston Globe
8 days ago BioPharm Insight Releases American Society of Hematology’s 2016 Annual Meeting (ASH) Preconference Report - Business Wire
8 days ago Genentech’s Ocrevus Pioneering The Progressive MS Therapy Landscape - PharmaceuticalOnline
8 days ago Cornerstone Pharma appoints CMO - NJ Biz
8 days ago The Corporate Reputation of Pharma 2015 - The Perspective of 118 Patient Groups with an Interest in Respiratory Conditions - Business Wire
8 days ago What Happens When Your Biotech Stock Faces Generic Competition Lawsuits? - FOX Business

Create a custom search

News search supports Google type search formatting and the use of complex boolean. Wrap terms in double quotes for exact phrase matching. Click + to add multiple news search terms to this topic.